Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase

Juliana Ruiz-Caro, Aravind Basavapathruni, Joseph T. Kim, Christopher M. Bailey, Ligong Wang, Karen S. Anderson, Andrew Hamilton, William L. Jorgensen

Research output: Contribution to journalArticle

Abstract

Following computational analyses, potential non-nucleoside inhibitors of HIV-1 reverse transcriptase have been pursued through synthesis and assaying for anti-viral activity. The general class Het-NH-Ph-U has been considered, where Het is an aromatic heterocycle and U is an unsaturated, hydrophobic group. Results for compounds with Het = 2-thiazoyl and 2-pyrimidinyl are the focus of this report.

Original languageEnglish (US)
Pages (from-to)668-671
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume16
Issue number3
DOIs
StatePublished - Feb 1 2006

Fingerprint

Human immunodeficiency virus 1 reverse transcriptase

Keywords

  • Anti-HIV drug
  • Computer-aided drug design
  • Diarylamine
  • NNRTI
  • Pyrimidinylamine
  • Thiazoylamine

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Ruiz-Caro, J., Basavapathruni, A., Kim, J. T., Bailey, C. M., Wang, L., Anderson, K. S., ... Jorgensen, W. L. (2006). Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic and Medicinal Chemistry Letters, 16(3), 668-671. https://doi.org/10.1016/j.bmcl.2005.10.037

Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase. / Ruiz-Caro, Juliana; Basavapathruni, Aravind; Kim, Joseph T.; Bailey, Christopher M.; Wang, Ligong; Anderson, Karen S.; Hamilton, Andrew; Jorgensen, William L.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 16, No. 3, 01.02.2006, p. 668-671.

Research output: Contribution to journalArticle

Ruiz-Caro, J, Basavapathruni, A, Kim, JT, Bailey, CM, Wang, L, Anderson, KS, Hamilton, A & Jorgensen, WL 2006, 'Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase', Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 3, pp. 668-671. https://doi.org/10.1016/j.bmcl.2005.10.037
Ruiz-Caro, Juliana ; Basavapathruni, Aravind ; Kim, Joseph T. ; Bailey, Christopher M. ; Wang, Ligong ; Anderson, Karen S. ; Hamilton, Andrew ; Jorgensen, William L. / Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase. In: Bioorganic and Medicinal Chemistry Letters. 2006 ; Vol. 16, No. 3. pp. 668-671.
@article{f80031ee56904300846afa44637f895b,
title = "Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase",
abstract = "Following computational analyses, potential non-nucleoside inhibitors of HIV-1 reverse transcriptase have been pursued through synthesis and assaying for anti-viral activity. The general class Het-NH-Ph-U has been considered, where Het is an aromatic heterocycle and U is an unsaturated, hydrophobic group. Results for compounds with Het = 2-thiazoyl and 2-pyrimidinyl are the focus of this report.",
keywords = "Anti-HIV drug, Computer-aided drug design, Diarylamine, NNRTI, Pyrimidinylamine, Thiazoylamine",
author = "Juliana Ruiz-Caro and Aravind Basavapathruni and Kim, {Joseph T.} and Bailey, {Christopher M.} and Ligong Wang and Anderson, {Karen S.} and Andrew Hamilton and Jorgensen, {William L.}",
year = "2006",
month = "2",
day = "1",
doi = "10.1016/j.bmcl.2005.10.037",
language = "English (US)",
volume = "16",
pages = "668--671",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase

AU - Ruiz-Caro, Juliana

AU - Basavapathruni, Aravind

AU - Kim, Joseph T.

AU - Bailey, Christopher M.

AU - Wang, Ligong

AU - Anderson, Karen S.

AU - Hamilton, Andrew

AU - Jorgensen, William L.

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Following computational analyses, potential non-nucleoside inhibitors of HIV-1 reverse transcriptase have been pursued through synthesis and assaying for anti-viral activity. The general class Het-NH-Ph-U has been considered, where Het is an aromatic heterocycle and U is an unsaturated, hydrophobic group. Results for compounds with Het = 2-thiazoyl and 2-pyrimidinyl are the focus of this report.

AB - Following computational analyses, potential non-nucleoside inhibitors of HIV-1 reverse transcriptase have been pursued through synthesis and assaying for anti-viral activity. The general class Het-NH-Ph-U has been considered, where Het is an aromatic heterocycle and U is an unsaturated, hydrophobic group. Results for compounds with Het = 2-thiazoyl and 2-pyrimidinyl are the focus of this report.

KW - Anti-HIV drug

KW - Computer-aided drug design

KW - Diarylamine

KW - NNRTI

KW - Pyrimidinylamine

KW - Thiazoylamine

UR - http://www.scopus.com/inward/record.url?scp=29544437257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29544437257&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2005.10.037

DO - 10.1016/j.bmcl.2005.10.037

M3 - Article

VL - 16

SP - 668

EP - 671

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 3

ER -